Kazuo Yamashiro Selected Research

Kazuo Yamashiro Research Topics

Disease

17	Stroke (Strokes) 06/2023 - 08/2010
16	Ischemic Stroke 06/2023 - 03/2013
6	Cognitive Dysfunction 03/2024 - 01/2019
6	Hypertension (High Blood Pressure) 01/2021 - 03/2014
6	Infarction (Infarctions) 01/2021 - 01/2016
5	Atherosclerosis 06/2023 - 11/2009
5	Ischemia 01/2023 - 01/2016
5	Parkinson Disease (Parkinson's Disease) 01/2021 - 05/2008
4	Neuroinflammatory Diseases 03/2024 - 12/2020
4	Hemorrhage 12/2022 - 11/2012
4	Orthostatic Hypotension (Postural Hypotension) 01/2021 - 09/2015
4	Cerebral Infarction 01/2017 - 10/2012
3	Thrombophilia 06/2023 - 11/2012
3	Inflammation (Inflammations) 01/2023 - 01/2016
3	Atrial Fibrillation 12/2022 - 06/2019
3	Embolic Stroke 09/2022 - 02/2014
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2018 - 01/2016
3	Adenomyosis 08/2014 - 10/2012
2	Carotid Stenosis (Carotid Artery Stenosis) 01/2023 - 01/2019
2	Neoplasms (Cancer) 01/2022 - 10/2012
2	Dementia (Dementias) 01/2021 - 01/2020
2	Brain Ischemia (Cerebral Ischemia) 01/2021 - 01/2016
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 12/2013
2	Atherosclerotic Plaque (Atheroma) 11/2019 - 11/2009
2	Hyperglycemia 01/2018 - 01/2016
2	Transient Ischemic Attack 10/2017 - 01/2015
2	Intracranial Embolism 04/2015 - 03/2013
2	Prediabetic State (Prediabetes) 01/2015 - 09/2013
2	Glucose Intolerance 01/2015 - 09/2013
1	Alzheimer Disease (Alzheimer's Disease) 03/2024
1	Endocarditis 06/2023
1	Paradoxical Embolism 06/2023
1	Obesity 01/2023
1	Dysbiosis 01/2023
1	Embolism (Embolus) 12/2022
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 09/2022
1	Brain Diseases (Brain Disorder) 12/2021
1	Hashimoto's encephalitis 12/2021
1	COVID-19 12/2021
1	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 12/2021
1	Vertebral Artery Dissection 01/2021
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2021
1	Atrophy 01/2021
1	Endotoxemia 12/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2020
1	Peripheral Arterial Disease 09/2020
1	Hemorrhagic Stroke 09/2020
1	Blindness (Hysterical Blindness) 01/2019

Drug/Important Bio-Agent (IBA)

5	fibrin fragment D (D-dimer)IBA 09/2022 - 10/2012
5	Glucose (Dextrose)FDA LinkGeneric 10/2018 - 09/2013
4	AnticoagulantsIBA 12/2022 - 12/2013
4	hydroxide ionIBA 01/2021 - 09/2015
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2009
3	CytokinesIBA 01/2023 - 01/2016
3	Neuroprotective AgentsIBA 04/2021 - 11/2019
3	Eicosapentaenoic AcidIBA 09/2020 - 07/2018
2	Volatile Fatty AcidsIBA 03/2024 - 01/2021
2	danaparoid (Orgaran)FDA Link 06/2023 - 01/2014
2	LipopolysaccharidesIBA 01/2023 - 01/2021
2	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 06/2019
2	Messenger RNA (mRNA)IBA 12/2021 - 11/2009
2	Arachidonic Acid (Vitamin F)IBA 09/2020 - 07/2018
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 09/2020 - 11/2019
2	Docosahexaenoic AcidsIBA 11/2019 - 07/2018
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2016
2	oxidized low density lipoproteinIBA 04/2015 - 03/2013
2	Rosuvastatin Calcium (Crestor)FDA Link 04/2015 - 02/2014
2	Tumor Biomarkers (Tumor Markers)IBA 11/2012 - 10/2012
1	Butyrates (Butyrate)IBA 03/2024
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023
1	COVID-19 VaccinesIBA 12/2021
1	AntibodiesIBA 12/2021
1	Phosphopyruvate Hydratase (Enolase)IBA 12/2021
1	RNA (Ribonucleic Acid)IBA 12/2021
1	SteroidsIBA 12/2021
1	Carnitine (L-Carnitine)FDA LinkGeneric 04/2021
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2021
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2021
1	Antiphospholipid AntibodiesIBA 01/2021
1	LigandsIBA 01/2021
1	Anticardiolipin AntibodiesIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2020
1	Conditioned Culture MediaIBA 01/2020
1	Tranexamic Acid (AMCA)FDA Link 01/2019
1	Nicardipine (Dagan)FDA LinkGeneric 01/2019
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2019
1	Phenytoin (Dilantin)FDA LinkGeneric 01/2019
1	Methylprednisolone FDA LinkGeneric 01/2019
1	Glycerol (Glycerine)FDA LinkGeneric 01/2019
1	Glial Fibrillary Acidic ProteinIBA 10/2018
1	Oxygen (Dioxygen)IBA 10/2018
1	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 10/2018

Therapy/Procedure

6	Therapeutics 12/2022 - 02/2014
2	Aftercare (After-Treatment) 10/2018 - 10/2012
1	Fat-Restricted Diet (Diet, Fat Restricted) 01/2023
1	Secondary Prevention 12/2022
1	Renal Dialysis (Hemodialysis) 04/2021
1	Oral Administration 12/2020